Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

Phadia 2500EE instrument -Intended for the in vitro semi-quantitative measurement Recalled by Phadia US Inc Due to Higher reported results when running EliA GliadinDP IgG...

Date: May 1, 2023
Company: Phadia US Inc
Status: Ongoing
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Phadia US Inc directly.

Affected Products

Phadia 2500EE instrument -Intended for the in vitro semi-quantitative measurement of IgG antibodies directed to gliadin in human serum or plasma (Li-heparin, EDTA) to aid in the diagnosis of celiac disease Material Number 12410002

Quantity: 9 units

Why Was This Recalled?

Higher reported results when running EliA GliadinDP IgG Well on the instruments Phadia 2500EE compared to running EliA GliadinDP IgG Well on Phadia 250 instrument

Where Was This Sold?

This product was distributed to 3 states: CA, MI, NJ

Affected (3 states)Not affected

About Phadia US Inc

Phadia US Inc has 9 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report